We found statistically significant differences between MS and control group when analyzing TAS2R16 gene rs860170 polymorphism genotypes (TT, CT, and CC) distribution in males (20%, 64.5%, and 6.5% vs. 33.3%, 66.7%, and 0%, p = 0.036) (Table 10). The gene discussed is TAS2R16; the disease is myeloid sarcoma.